EKF Diagnostics Holdings Plc - Asset Resilience Ratio

Latest as of December 2024: -1.58%

EKF Diagnostics Holdings Plc (EKF) has an Asset Resilience Ratio of -1.58% as of December 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read EKF total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

GBX-1.29 Million
≈ $-156.83 USD Cash + Short-term Investments

Total Assets

GBX81.75 Million
≈ $9.95K USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (2009–2024)

This chart shows how EKF Diagnostics Holdings Plc's Asset Resilience Ratio has changed over time. See what is EKF Diagnostics Holdings Plc's book value for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down EKF Diagnostics Holdings Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of EKF Diagnostics Holdings Plc.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents GBX0.00 0%
Short-term Investments GBX-1.29 Million -1.58%
Total Liquid Assets GBX-1.29 Million -1.58%

Asset Resilience Insights

  • Limited Liquidity: EKF Diagnostics Holdings Plc maintains only -1.58% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company primarily holds liquidity in cash and equivalents rather than short-term investments.

EKF Diagnostics Holdings Plc Industry Peers by Asset Resilience Ratio

Compare EKF Diagnostics Holdings Plc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shenzhen New Industries Biomedical
SHE:300832
Medical Devices 9.95%
Jafron Biomedical Co Ltd
SHE:300529
Medical Devices 36.63%
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298
Medical Devices 2.82%
Shanghai ZJ Bio-Tech Co. Ltd. A
SHG:688317
Medical Devices 9.52%
Guangdong Transtek Medical Electronics Co Ltd
SHE:300562
Medical Devices 14.72%
Emvision Medical Devices Ltd
AU:EMV
Medical Devices 0.47%
DRGEM Corporation
KQ:263690
Medical Devices 0.50%
Diagnostic Medical Systems SA
PA:ALDMS
Medical Devices 1.39%

Annual Asset Resilience Ratio for EKF Diagnostics Holdings Plc (2009–2024)

The table below shows the annual Asset Resilience Ratio data for EKF Diagnostics Holdings Plc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2024-12-31 -1.58% GBX-1.29 Million
≈ $-156.83
GBX81.75 Million
≈ $9.95K
-1.66pp
2011-12-31 0.09% GBX51.00K
≈ $6.21
GBX58.73 Million
≈ $7.15K
-0.19pp
2010-12-31 0.28% GBX100.00K
≈ $12.17
GBX35.98 Million
≈ $4.38K
-7.12pp
2009-12-31 7.39% GBX473.00K
≈ $57.55
GBX6.40 Million
≈ $778.33
--
pp = percentage points

About EKF Diagnostics Holdings Plc

LSE:EKF UK Medical Devices
Market Cap
$1.39 Million
GBX11.46 Billion GBX
Market Cap Rank
#29998 Global
#743 in UK
Share Price
GBX26.55
Change (1 day)
-0.56%
52-Week Range
GBX19.80 - GBX31.90
All Time High
GBX78.21
About

EKF Diagnostics Holdings plc engages in the design, development, manufacture, and sale of diagnostic instruments, reagents, and other ancillary products in the Americas, Europe, the Middle East, Asia, Africa, and internationally. The company offers DiaSpect Tm hand-held hemoglobin analyzer; Hemo Control, a hemoglobin and hematocrit analyzer; and HemataStat II, a microhematocrit centrifuge that pr… Read more